PedAM
Pediatric Disease Annotations & Medicines
| Disease | vascular disease |
| Phenotype | C0028754|adiposity |
| Sentences | 16 |
| PubMedID- 26016847 | adiposity as a cause of cardiovascular disease: a mendelian randomization study. |
| PubMedID- 21147855 | Background: cross-sectional data indicate that central adiposity is associated with cardiovascular disease risk, independent of total adiposity. |
| PubMedID- 23850922 | Conclusions: visceral adiposity is associated with incident cardiovascular disease and cancer after adjustment for clinical risk factors and generalized adiposity. |
| PubMedID- 21397319 | Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies. |
| PubMedID- 25880905 | This is of major concern as excess adiposity is strongly associated with cardiovascular disease (cvd) risk factors such as hypertension, diabetes mellitus and dyslipidemia [2,3]. |
| PubMedID- 25990690 | Cardiovascular diseases are associated with adiposity opposed to dementia with fat loss. |
| PubMedID- 21477496 | Introduction: body mass index (bmi) and indicators of central adiposity have been associated with cardiovascular disease (cvd) risk factors, but ambiguity remains about which measure optimally predicts cvd risk and is best suited for different racial/ethnic groups. |
| PubMedID- 23512375 | Objective: to evaluate the association of body adiposity index (bai) with all-cause and cardiovascular disease (cvd) mortality risk. |
| PubMedID- 22429873 | The link between adiposity and the development of metabolic and cardiovascular diseases may be seen in obesity-related systemic inflammation [7,8]. |
| PubMedID- 21039443 | The relation between thyroid-stimulating hormone and measures of adiposity in patients with manifest vascular disease. |
| PubMedID- 22503065 | Objective: to investigate associations of cardiorespiratory fitness (crf) and different measures of adiposity with cardiovascular disease (cvd) and all-cause mortality in men with known or suspected coronary heart disease (chd). |
| PubMedID- 25575429 | Aim: the study investigated the relationship of general (body mass index [bmi]) and central (waist circumference [wc]; waist-hip ratio [whipr]; waist-height ratio [wheightr]) adiposity with all-cause and cardiovascular disease (cvd)-related mortality in an asian population with diabetes. |
| PubMedID- 23577240 | Visceral adiposity is predictive of hepatic steatosis, cardiovascular disease, and type 2 diabetes, whereas an increase in the mass of subcutaneous fat appears to pose little or no risk of these conditions [4]. |
| PubMedID- 22508709 | Objective: our objective was to describe the relationship between intramyocellular lipid (imcl) accumulation and 1) visceral adiposity and 2) markers of insulin resistance and cardiovascular disease risk in a cohort of prepubertal and early pubertal children. |
| PubMedID- 22337910 | Prevalent cardiovascular disease increased with visceral adiposity tertiles, regardless of type 2 diabetes status. |
| PubMedID- 23146089 | The heart outcomes prevention evaluation (hope) study reported that abdominal adiposity reduced the prognosis of patients with cardiovascular disease (cvd)[30]. |
Page: 1